TRX 211
Alternative Names: TRX-211; TRX-211-399Latest Information Update: 21 Jun 2024
At a glance
- Originator Therapex
- Class Antineoplastics
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Non-small cell lung cancer
Most Recent Events
- 21 Jun 2024 Preclinical trials in Non-small cell lung cancer in South Korea (PO) prior to April 2024
- 05 Apr 2024 Pharmacokinetics and pharmacodynamics data from preclinical studies in Non-small cell lung cancer presented at the 115th Annual Meeting of the American Association for Cancer Research (AACR-2024)
- 21 Jun 2023 Early research in Non-small cell lung cancer in South Korea prior to June 2023 (unspecified route) (Therapex pipeline, June 2023)